Navigation Links
IsoTis Adjourns Special Meeting to October 26, 2007
Date:10/24/2007

s stockholders a definitive proxy statement and other relevant documents in connection with the special stockholder meeting for the proposed transaction. IsoTis stockholders are urged to read the definitive proxy statement and other relevant materials when they become available because they will contain important information about IsoTis, Integra and the proposed transaction. Investors may obtain a free copy of these materials and other documents filed by IsoTis with the Securities and Exchange Commission at the SEC's website at http://www.sec.gov, at IsoTis' website at http://www.isotis.com or by sending a written request to IsoTis at 2 Goodyear, Irvine, California 92618, Attention: Chief Financial Officer.

IsoTis and its directors, executive officers and certain other members of management and employees may be deemed to be participants in soliciting proxies from its stockholders in favor of the proposed merger. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of IsoTis' stockholders in connection with the proposed transaction will be set forth in IsoTis' revised definitive proxy statement for its special meeting. Additional information regarding these individuals and any interest they have in the proposed transaction is set forth in the revised definitive proxy statement when it is filed with the SEC.


'/>"/>
SOURCE IsoTis Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Calcium Plus Assay Kit, Superior Detection for Specialized Targets
2. Neurognostics receives special FDA clearance for MindState fDAD
3. Berbee designated a Microsoft Small Business Specialist
4. Special needs addressed at Web Usability Conference
5. OASYS Online Provides Special Education Data Management
6. AG accuses BioCATT of violating meetings law
7. VC trends, company progress discussed at Mason Wells portfolio meeting
8. Beware the Dreaded Off-Site Technology Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...nghaiBiolaxyannouncedthe,ChineseStateFood&Drug...newdrugapplication(IND)foritsoralinsulinproject,(N...es.ThisIND,approvalallowsBiolaxytoinitiateitsfirst...racteristicofhighbloodglucoseandpoor,metabolism.Th...nd,macro-vasculardiseases,lossofvision,kidneyfailu...
(Date:11/24/2009)...proved the Promega PowerPlex 16 HS System for use ... records for the National DNA Index System. , ...e FBI recently approved the Promega PowerPlex®...ing in, or generating DNA records for, the Nationa... more than seven million profiles and has assisted...
(Date:11/24/2009)...PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HTL...ancedlasersystemsandinstrumentsforthestemcellresea...nalandfinancialresultsforthethirdquarterendedSepte...6millioncomparedwith$1.43millioninQ32008,-Grosspro...,2008,-Netlossreducedto$148,000comparedto$283,000i...
(Date:11/24/2009)...Call/--ArenaPharmaceuticals,Inc.(Nasdaq: ARNA )ann...hePiperJaffray21stAnnualHealthCareConferenceonDece...me)attheNewYorkPalaceHotelinNewYorkCity.JackLief,A...ledtoprovideanoverviewofthecompany,includingitscli...udiowebcastofthepresentationwillbeavailableunderth...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...., Jan. 28 Campbell Alliance, the leading,managem...ical and,biotechnology industries, today announced...he firm,s Brand Management practice, will speak at...t will be held on January,30-31, 2008, at the Rege... Naeymi-Rad,s presentation, titled "Key Success Fa...
...nn., Jan. 28 Alexion,Pharmaceuticals, Inc. (Nasda...conduct a conference call and audio web cast on Th...me (ET), in conjunction with the release of,its fi...ar ended December,31, 2007. Alexion anticipates re...hursday, February 14, 2008., To participate in th...
....J., Jan. 28 Arno Therapeutics, Inc., a,privately...has entered into,worldwide, exclusive license agre...the rights to commercially develop novel, orally a... to the license agreements, Arno acquired the righ... cancer, including OSU-03012 (NSC,D728209) and OSU...
Other Biology Technology:Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit 2Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 2Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 3
(Date:11/24/2009)...arteries from collapsing have been true life-saver...r needed -- once the arteries are strengthened, th...choice but to leave them in place. , Prof. Meita... Biomedical Engineering has developed a new patent...hey,re needed, then dissolves. , "Our new compos...
(Date:11/24/2009)...er of debate. A high-profile study a few years ago...r carbon from trees and leaves, evidence for a ver...cosystems. , But new research from the Universit...e. Algae provide a much richer diet for fish and o... this week in the Proceedings of the National Aca...
(Date:11/23/2009)...09 Applied mathematicians dissected the morpholog...racteristic long leaf with a saddle-like arc midse...The simple cause of the lily,s fan-like shapeelast...ential growthwas revealed by using an equally simp...iang, a postdoctoral student at Harvard,s School o...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2New device detects heart disease using less than one drop of blood 8672 1New device detects heart disease using less than one drop of blood 8672 2Vaccine shows therapeutic promise against advanced melanoma 47471 1Vaccine shows therapeutic promise against advanced melanoma 47471 2Vaccine shows therapeutic promise against advanced melanoma 47471 3Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 1Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 2
...te a down economy, Safeway Inc. presented a $685,2...he Translational Genomics Research Institute (TGen...ix Division, which includes 116 stores throughout ... employees for stepping up for scientific research...zation as TGen. I think everybody recognizes that,...
...Ben-Gurion University of the Negev engineers have ...ted in large nuclear reactors, making it unsuitabl...m 241), a form of the basic synthetic element foun...ges, plutonium can only be used for peaceful purpo...an a dozen countries developing nuclear reactors i...
...iological diversity is now being called into quest...ar legislation entails that biological diversity f...y affects coordinated efforts, according to Aalhei...fend her dissertation in environmental law. Inter...versity, the object of study, is called into quest...
Other Biology News:Safeway gives $685,000 to TGen for breast cancer research 2Ben-Gurion University engineers develop technique to help combat nuclear proliferation 2
Anti-Human C3a / C3a des-Arg (neo-epitope) Monoclonal Antibody, Unconjugated, Clone 2991 from Cell Sciences
Rabbit Anti-Warfarin Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-MA2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
Biology Products: